These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36994805)

  • 1. Lived experiences of Oxford House residents prescribed medication-assisted treatment.
    Soto-Nevarez A; Abo M; Hudson M; Bobak T; Jason LA
    J Community Psychol; 2023 Sep; 51(7):2828-2844. PubMed ID: 36994805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow Residents.
    Majer JM; Beasley C; Stecker E; Bobak TJ; Norris J; Nguyen HM; Ogata M; Siegel J; Wiedbusch E; Dovale I; Gelfman N; Callahan S; Jason LA
    Community Ment Health J; 2018 Jul; 54(5):571-577. PubMed ID: 29302767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.
    Maradiaga JA; Nahvi S; Cunningham CO; Sanchez J; Fox AD
    J Subst Abuse Treat; 2016 Mar; 62():49-54. PubMed ID: 26747509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B; Gilmour J; Deering D
    Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.
    Uebelacker LA; Bailey G; Herman D; Anderson B; Stein M
    J Subst Abuse Treat; 2016 Jul; 66():48-53. PubMed ID: 27211996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
    Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
    Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intent to Refer: Exploring Bias Toward Specific Medication-Assisted Treatments by Community Corrections Employees.
    Streisel SE
    Subst Use Misuse; 2018 Dec; 53(14):2421-2430. PubMed ID: 29958042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.
    Maglione MA; Raaen L; Chen C; Azhar G; Shahidinia N; Shen M; Maksabedian E; Shanman RM; Newberry S; Hempel S
    J Subst Abuse Treat; 2018 Jun; 89():28-51. PubMed ID: 29706172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance of medications for opioid use disorder in recovery housing programs in Missouri.
    Wood CA; Duello A; Miles J; Lohmann B; Gochez-Kerr T; Richardson K; Anderson-Harper R; Winograd RP
    J Subst Abuse Treat; 2022 Jul; 138():108747. PubMed ID: 35248406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of drug treatment and recovery services: an opportunity to address injection initiation assistance in Tijuana, Mexico.
    Meyers SA; Rafful C; Jain S; Sun X; Skaathun B; Guise A; Gonzalez-Zuñiga P; Strathdee SA; Werb D; Mittal ML
    Subst Abuse Treat Prev Policy; 2020 Oct; 15(1):78. PubMed ID: 33046125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review.
    Feelemyer J; Des Jarlais D; Arasteh K; Abdul-Quader AS; Hagan H
    Addiction; 2014 Jan; 109(1):20-32. PubMed ID: 23859638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.
    Gryczynski J; Jaffe JH; Schwartz RP; Dušek KA; Gugsa N; Monroe CL; O'Grady KE; Olsen YK; Mitchell SG
    Am J Addict; 2013; 22(3):285-91. PubMed ID: 23617873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between dissociative symptoms and the medications used in the treatment of opioid use disorder.
    Gainer DM; Crawford TN; Fischer KB; Wright MD
    J Subst Abuse Treat; 2021 Feb; 121():108195. PubMed ID: 33357605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of Treatments for Opioid Use Disorder.
    Fairley M; Humphreys K; Joyce VR; Bounthavong M; Trafton J; Combs A; Oliva EM; Goldhaber-Fiebert JD; Asch SM; Brandeau ML; Owens DK
    JAMA Psychiatry; 2021 Jul; 78(7):767-777. PubMed ID: 33787832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of opioid use disorder in pregnancy.
    Rodriguez CE; Klie KA
    Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
    McElrath K; Joseph H
    Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.